Loading...

AMBALALSA Ambalal Sarabhai Enterprises Ltd US FDA Inspection Announcement

mbll

MBLL

Ambalal Sarabhai Enterprises Ltd

(AMBALALSA)

2025 Announcement

Newspaper publication

Unaudited results

Unaudited results

SPAC Transaction Announcement

Board Meeting Notice

Award Recognition

Compliance Certificate

Financial Results Published

AGM Notice Published

Compliance Certificate Subm...

Financial Results Published

Annual Compliance Report

Compliance Certificate

Financial Results Published

Compliance Certificate

New Distribution Agreement

Financial Results Published

Demerger Announcement

Compliance Certificate

Plant Closure Announcement

Financial Results

Compliance Certificate Subm...

Resignation of CFO

Newspaper Advertisement

Report Submission

Financial Results Published

New Appointments

Board Meeting Outcome

Change in Management

Compliance Certificate

Compliance Certificate Subm...

Certificate Submission

Management Change

Directorate Change

Board Meeting Update

Directorate Change

Reconstitution of Committees

Management Change

Newspaper Publication

BSE Fine Imposed

Results Publication

Additional Details Required...

Management Change

Website updation

Compliance Certificate Subm...

Management Changes

appointment and resignation

Legal Settlement

Newspaper Publication

Postal Ballot Notice

Certificate under Regulatio...

Change in Contact Details

Appointment of Company Secr...

Resignation of Company Secr...

Appointment of Director

Rescheduling of Board Meeting

Scheme of Arrangement

Financial Statements

Geographic Expansion

Financial Results Publication

External Links:

Data:

Ambalal Sarabhai Enterprises Ltd's subsidiary Synbiotics Ltd received its 6th consecutive approval from USFDA for GMP compliance, after an inspection in April 2025.

AI Assistant

Ambalal Sarabhai Enterprises Ltd

2025

Announcement

Find Answers

Ask about any part of the document to get insights, explanations, or key details.